Tolerance to allopregnanolone with focus on the GABA-A receptor

British Journal of Pharmacology

Volumn 162, Issue 2, 2011, Pages 311-327

  Turkmen, Sahruh ^a,b   Backstrom, Torbjorn ^b   Wahlstrom, Goran ^c   Andreen, Lotta ^a,b   Johansson, Inga Maj ^b  

^a Sundsvall County Hospital   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

allopregnanolone; GABA A receptor; mRNA; neurosteroid; silent second; tolerance

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ELTANOLONE; ENIBOMAL; ESTROGEN; FINASTERIDE; FLUNITRAZEPAM; FLURAZEPAM; GANAXOLONE; GESTAGEN; HEXOBARBITAL; MESSENGER RNA; METHOHEXITAL; MINAXOLONE; MUSCIMOL; NEUROSTEROID; PENTOBARBITAL; PLACEBO; PROPOFOL; SEX HORMONE; THIOPENTAL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZOLPIDEM;

ACUTE STRESS; ARTICLE; CATAMENIAL EPILEPSY; CHRONIC STRESS; DRUG ANTAGONISM; DRUG CROSS TOLERANCE; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG TISSUE LEVEL; DRUG TOLERANCE; DRUG WITHDRAWAL; GABAERGIC SYSTEM; GENE EXPRESSION REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN VIVO STUDY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; MENTAL DISEASE; MOOD CHANGE; NONHUMAN; POSTMENOPAUSE; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SEDATION; SEIZURE; SIDE EFFECT; WITHDRAWAL SYNDROME;

ANIMALS; DRUG TOLERANCE; FEMALE; GAMMA-AMINOBUTYRIC ACID; GONADAL STEROID HORMONES; HUMANS; PREGNANCY; PREGNANOLONE; PROGESTERONE; RATS; RECEPTORS, GABA-A; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 78650359548     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01059.x     Document Type: Article

References (198)

1. Allan AM, Zhang X, Baier LD, (1992). Barbiturate tolerance: effects on GABA-operated chloride channel function. Brain Res 588: 255-260.
2. Allison C, Pratt JA, (2003). Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 98: 171-195.
3. Andreen L, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom T, (2006). Allopregnanolone concentration and mood-a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) 187: 209-221.
4. Antkowiak B, (1999). Different actions of general anesthetics on the firing patterns of neocortical neurons mediated by the GABA(A) receptor. Anesthesiology 91: 500-511.
5. Aston R, (1966). Acute tolerance indices for pentobarbital in male and female rats. J Pharmacol Exp Ther 152: 350-353.
6. Backstrom T, (1976). Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 54: 321-347.
7. Backstrom T, Gee KW, Lan N, Sorensen M, Wahlstrom G, (1990). Steroids in relation to epilepsy and anaesthesia. Ciba Found Symp 153: 225-230; discussion 230-239.
8. Backstrom T, Andersson A, Andree L, Birzniece V, Bixo M, Bjorn I, et al. (2003). Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 1007: 42-53.
9. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, et al. (1998). International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50: 291-313.
10. Barnes EM Jr, (2000). Intracellular trafficking of GABA(A) receptors. Life Sci 66: 1063-1070.
11. Bateson AN, (2002). Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8: 5-21.
12. Beckley EH, Fretwell AM, Tanchuck MA, Gililland KR, Crabbe JC, Finn DA, (2008). Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice. Neuropharmacology 54: 365-374.
13. Belelli D, Lambert JJ, (2005). Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6: 565-575.
14. Belelli D, Pistis M, Peters JA, Lambert JJ, (1999). The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors. Neurochem Int 34: 447-452.
15. Bicikova M, Klak J, Hill M, Zizka Z, Hampl R, Calda P, (2002). Two neuroactive steroids in midpregnancy as measured in maternal and fetal sera and in amniotic fluid. Steroids 67: 399-402.
16. Biggio G, Dazzi L, Biggio F, Mancuso L, Talani G, Busonero F, et al. (2003). Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators. Eur Neuropsychopharmacol 13: 411-423. (Pubitemid 37433962)
17. Biggio G, Concas A, Follesa P, Sanna E, Serra M, (2007). Stress, ethanol, and neuroactive steroids. Pharmacol Ther 116: 140-171.
18. Birke G, Draguhn A, (2010). No simple brake-the complex functions of inhibitory synapses. Pharmacopsychiatry 43 (Suppl. 1): S21-S31.
19. Birzniece V, Turkmen S, Lindblad C, Zhu D, Johansson IM, Backstrom T, et al. (2006). GABA(A) receptor changes in acute allopregnanolone tolerance. Eur J Pharmacol 535: 125-134.
20. Bitran D, Hilvers RJ, Kellogg CK, (1991). Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561: 157-161.
21. Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T, (1997). Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20- one in specific regions of the human female brain in different endocrine states. Brain Res 764: 173-178.
22. Bjorn I, Bixo M, Nojd KS, Nyberg S, Backstrom T, (2000). Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 183: 1419-1426.
23. Bloch M, Rotenberg N, Koren D, Klein E, (2006). Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 28: 3-8.
24. Brandon N, Jovanovic J, Moss S, (2002). Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid(A) receptor function and cell surface expression. Pharmacol Ther 94: 113-122.
25. Brodie BB, Mark LC, Lief PA, Bernstein E, Papper EM, (1951). Acute tolerance to thiopental. J Pharmacol Exp Ther 102: 215-218.
26. Brussaard AB, Koksma JJ, (2002). Short-term modulation of GABAA receptor function in the adult female rat. Prog Brain Res 139: 31-42.
27. Brussaard AB, Koksma JJ, (2003). Conditional regulation of neurosteroid sensitivity of GABAA receptors. Ann N Y Acad Sci 1007: 29-36.
28. Chastain G, (2006). Alcohol, neurotransmitter systems, and behavior. J Gen Psychol 133: 329-335.
29. Chen ZW, Olsen RW, (2007). GABAA receptor associated proteins: a key factor regulating GABAA receptor function. J Neurochem 100: 279-294.
30. Chien YW, (1981). Long-acting parenteral drug formulations. J Parenter Sci Technol 35: 106-139.
31. Concas A, Mostallino MC, Porcu P, Follesa P, Barbaccia ML, Trabucchi M, et al. (1998). Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci USA 95: 13284-13289.
32. Concas A, Follesa P, Barbaccia ML, Purdy RH, Biggio G, (1999). Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur J Pharmacol 375: 225-235.
33. Corpechot C, Young J, Calvel M, Wehrey C, Veltz JN, Touyer G, et al. (1993). Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133: 1003-1009.
34. Costa AM, Spence KT, Smith SS, ffrench-Mullen JM, (1995). Withdrawal from the endogenous steroid progesterone results in GABAA currents insensitive to benzodiazepine modulation in rat CA1 hippocampus. J Neurophysiol 74: 464-469.
35. Cullberg J, (1972). Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo. Acta Psychiatr Scand Suppl 236: 1-86.
36. Czlonkowska AI, Krzascik P, Sienkiewicz-Jarosz H, Siemiatkowski M, Szyndler J, Maciejak P, et al. (2001). Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures. Eur J Pharmacol 425: 121-127.
37. Damianisch K, Rupprecht R, Lancel M, (2001). The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology 25: 576-584.
38. Dazzi L, Sanna A, Cagetti E, Concas A, Biggio G, (1996). Inhibition by the neurosteroid allopregnanolone of basal and stress-induced acetylcholine release in the brain of freely moving rats. Brain Res 710: 275-280. (Pubitemid 26082057)
39. Demellweek C, Goudie AJ, (1983). Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms. Psychopharmacology (Berl) 80: 287-307. (Pubitemid 13043528)
40. Deutsch SI, Park CH, Hitri A, (1994). Allosteric effects of a GABA receptor-active steroid are altered by stress. Pharmacol Biochem Behav 47: 913-917.
41. Devaud LL, Purdy RH, Finn DA, Morrow AL, (1996). Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther 278: 510-517.
42. Devaud LL, Fritschy JM, Sieghart W, Morrow AL, (1997). Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 69: 126-130.
43. Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, et al. (2001). Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci USA 98: 2849-2854.
44. Drafts BC, Fisher JL, (2006). Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. J Pharmacol Exp Ther 318: 1094-1101.
45. Droogleever Fortuyn HA, van Broekhoven F, Span PN, Backstrom T, Zitman FG, Verkes RJ, (2004). Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29: 1341-1344.
46. Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C, (2007). Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology 32: 2190-2198.
47. Fancsik A, Linn DM, Tasker JG, (2000). Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J Neurosci 20: 3067-3075.
48. Finn DA, Gallaher EJ, Crabbe JC, (2000). Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J Pharmacol Exp Ther 292: 394-405.
49. Follesa P, Concas A, Porcu P, Sanna E, Serra M, Mostallino MC, et al. (2001). Role of allopregnanolone in regulation of GABA(A) receptor plasticity during long-term exposure to and withdrawal from progesterone. Brain Res Brain Res Rev 37: 81-90.
50. Follesa P, Biggio F, Talani G, Murru L, Serra M, Sanna E, et al. (2006). Neurosteroids, GABA(A) receptors, and ethanol dependence. Psychopharmacology (Berl) 186: 267-280.
51. Friedman L, Gibbs TT, Farb DH, (1993). Gamma-aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Mol Pharmacol 44: 191-197.
52. Ghoneim MM, Mewaldt SP, Berie JL, Hinrichs JV, (1981). Memory and performance effects of single and 3-week administration of diazepam. Psychopharmacology (Berl) 73: 147-151.
53. Girdler SS, Klatzkin R, (2007). Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther 116: 125-139.
54. Goldberg L, (1943). Quantitative studies on alcohol tolerance in man. The influence of ethyl alcohol on sensory, motor and psychological functions referred to blood alcohol in normal and habituated individuals. Acta Physiol Scand 5: 1-128.
55. Greenblatt DJ, Shader RI, (1978). Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Metab Rev 8: 13-28.
56. Grobin AC, Morrow AL, (2000). 3alpha-hydroxy-5alpha-pregnan-20-one exposure reduces GABA(A) receptor alpha4 subunit mRNA levels. Eur J Pharmacol 409: R1-R2.
57. Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E, (2001). The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev 37: 110-115.
58. Gulinello M, Gong QH, Li X, Smith SS, (2001). Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res 910: 55-66.
59. Gyenes M, Wang Q, Gibbs TT, Farb DH, (1994). Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor. Mol Pharmacol 46: 542-549.
60. Harrison NL, Majewska MD, Harrington JW, Barker JL, (1987). Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther 241: 346-353.
61. Hill M, Cibula D, Havlikova H, Kancheva L, Fait T, Kancheva R, et al. (2007). Circulating levels of pregnanolone isomers during the third trimester of human pregnancy. J Steroid Biochem Mol Biol 105: 166-175.
62. Himmelsbach C, (1941). The morphine abstinence syndrome: its nature and treatment. Ann Intern Med 15: 829-843.
63. Hoffman PL, Morrow A, Phillips T, Siggins G, (2000). Molecular and Cellular Adaptive Responses to Chronic Ethanol Exposure. US Government Printing Office: Washington, DC.
64. Holt RA, Bateson AN, Martin IL, (1996). Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology 35: 1457-1463.
65. Holt RA, Martin IL, Bateson AN, (1997). Chronic diazepam exposure decreases transcription of the rat GABA(A) receptor gamma2-subunit gene. Brain Res Mol Brain Res 48: 164-166.
66. Hosie AM, Wilkins ME, da Silva HM, Smart TG, (2006). Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444: 486-489.
67. Hosie AM, Clarke L, da Silva H, Smart TG, (2009). Conserved site for neurosteroid modulation of GABA A receptors. Neuropharmacology 56: 149-154.
68. Hughes LM, Wasserman EA, Hinrichs JV, (1984). Chronic diazepam administration and appetitive discrimination learning: acquisition versus steady-state performance in pigeons. Psychopharmacology (Berl) 84: 318-322.
69. Ihmsen H, Albrecht S, Hering W, Schuttler J, Schwilden H, (2004). Modelling acute tolerance to the EEG effect of two benzodiazepines. Br J Clin Pharmacol 57: 153-161.
70. Impagnatiello F, Pesold C, Longone P, Caruncho H, Fritschy JM, Costa E, et al. (1996). Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49: 822-831.
71. Ito T, Suzuki T, Wellman SE, Ho IK, (1996a). Pharmacology of barbiturate tolerance/dependence: GABAA receptors and molecular aspects. Life Sci 59: 169-195.
72. Ito T, Suzuki T, Wellman SE, Ho IK, (1996b). Chronic pentobarbital administration alters gamma-aminobutyric acidA receptor alpha 6-subunit mRNA levels and diazepam-insensitive [3H]Ro15-4513 binding. Synapse 22: 106-113.
73. Johansson T, Le Greves P, (2005). The effect of dehydroepiandrosterone sulfate and allopregnanolone sulfate on the binding of [(3)H]ifenprodil to the N-methyl-d-aspartate receptor in rat frontal cortex membrane. J Steroid Biochem Mol Biol 94: 263-266.
74. Johansson IM, Birzniece V, Lindblad C, Olsson T, Backstrom T, (2002). Allopregnanolone inhibits learning in the Morris water maze. Brain Res 934: 125-131.
75. Jovanovic JN, Thomas P, Kittler JT, Smart TG, Moss SJ, (2004). Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability. J Neurosci 24: 522-530.
76. Kalant H, (1993). Problems in the search for mechanisms of tolerance. Alcohol Alcohol Suppl 2: 1-8.
77. Kalant H, LeBlanc AE, Gibbins RJ, (1971). Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol Rev 23: 135-191.
78. Kan CC, Hilberink SR, Breteler MH, (2004). Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach. Compr Psychiatry 45: 88-94.
79. Kask K, Gulinello M, Backstrom T, Geyer MA, Sundstrom-Poromaa I, (2008). Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 33: 2283-2290.
80. Kauderer BS, Kandel ER, (2000). Capture of a protein synthesis-dependent component of long-term depression. Proc Natl Acad Sci USA 97: 13342-13347.
81. Kittler JT, Chen G, Honing S, Bogdanov Y, McAinsh K, Arancibia-Carcamo IL, et al. (2005). Phospho-dependent binding of the clathrin AP2 adaptor complex to GABAA receptors regulates the efficacy of inhibitory synaptic transmission. Proc Natl Acad Sci USA 102: 14871-14876.
82. Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB, (1997). Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneuroendocrinology 22: 549-558.
83. Klein RL, Harris RA, (1996). Regulation of GABAA receptor structure and function by chronic drug treatments in vivo and with stably transfected cells. Jpn J Pharmacol 70: 1-15.
84. Kokate TG, Yamaguchi S, Pannell LK, Rajamani U, Carroll DM, Grossman AB, et al. (1998). Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. J Pharmacol Exp Ther 287: 553-558.
85. Koksma JJ, van Kesteren RE, Rosahl TW, Zwart R, Smit AB, Luddens H, et al. (2003). Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition. J Neurosci 23: 788-797.
86. Korkmaz S, Wahlstrom G, (1997). The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats. Brain Res Brain Res Protoc 1: 378-384.
87. Korneyev A, Guidotti A, Costa E, (1993). Regional and interspecies differences in brain progesterone metabolism. J Neurochem 61: 2041-2047.
88. Krasowski MD, Harrison NL, (1999). General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 55: 1278-1303.
89. Laidlaw J, (1956). Catamenial epilepsy. Lancet 271: 1235-1237.
90. Lambert JJ, Belelli D, Harney SC, Peters JA, Frenguelli BG, (2001). Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroactive steroids. Brain Res Brain Res Rev 37: 68-80.
91. Landgren S, Aasly J, Backstrom T, Dubrovsky B, Danielsson E, (1987). The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol Scand 131: 33-42.
92. Laurijssens BE, Greenblatt DJ, (1996). Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin Pharmacokinet 30: 52-76.
93. Le AD, Kalant H, Khanna JM, (1987). Effects of treatment dose and intoxicated practice on the development of tolerance to ethanol-induced motor impairment. Alcohol Alcohol Suppl 1: 435-439.
94. Leblanc AE, Kalant H, Gibbins RJ, (1976). Acquisition and loss of behaviorally augmented tolerance to ethanol in the rat. Psychopharmacology (Berl) 48: 153-158.
95. Lin SC, Sutherland VC, (1977). Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence. Res Commun Chem Pathol Pharmacol 18: 215-231.
96. Loh EW, Ball D, (2000). Role of the GABA(A)beta2, GABA(A)alpha6, GABA(A)alpha1 and GABA(A)gamma2 receptor subunit genes cluster in drug responses and the development of alcohol dependence. Neurochem Int 37: 413-423.
97. Luisi S, Petraglia F, Benedetto C, Nappi RE, Bernardi F, Fadalti M, et al. (2000). Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 85: 2429-2433.
98. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, et al. (2000). Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3: 587-592.
99. McNamara RK, Skelton RW, (1997). Tolerance develops to the spatial learning deficit produced by diazepam in rats. Pharmacol Biochem Behav 56: 383-389.
100. Maguire J, Mody I, (2008). GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 59: 207-213.
101. Mahmoudi M, Kang MH, Tillakaratne N, Tobin AJ, Olsen RW, (1997). Chronic intermittent ethanol treatment in rats increases GABA(A) receptor alpha4-subunit expression: possible relevance to alcohol dependence. J Neurochem 68: 2485-2492.
102. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM, (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232: 1004-1007.
103. Marshall FH, Stratton SC, Mullings J, Ford E, Worton SP, Oakley NR, et al. (1997). Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure. Pharmacol Biochem Behav 58: 1-8.
104. Matsumoto K, Nomura H, Murakami Y, Taki K, Takahata H, Watanabe H, (2003). Long-term social isolation enhances picrotoxin seizure susceptibility in mice: up-regulatory role of endogenous brain allopregnanolone in GABAergic systems. Pharmacol Biochem Behav 75: 831-835.
105. Matthews DB, Devaud LL, Fritschy JM, Sieghart W, Morrow AL, (1998). Differential regulation of GABA(A) receptor gene expression by ethanol in the rat hippocampus versus cerebral cortex. J Neurochem 70: 1160-1166.
106. Meczekalski B, Tonetti A, Monteleone P, Bernardi F, Luisi S, Stomati M, et al. (2000). Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. Eur J Endocrinol 142: 280-285.
107. Mehta AK, Ticku MK, (1999). An update on GABAA receptors. Brain Res Brain Res Rev 29: 196-217.
108. Mellanby E, (1919). Alcohol: its absobtion into and disappearance from the blood under different conditions. ed. Report, M. R. C. S., pp.1-48.
109. Mellon SH, Griffin LD, (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 13: 35-43.
110. Mhatre MC, Ticku MK, (1992). Chronic ethanol administration alters gamma-aminobutyric acidA receptor gene expression. Mol Pharmacol 42: 415-422.
111. Mhatre MC, Ticku MK, (1994). Chronic GABA treatment downregulates the GABAA receptor alpha 2 and alpha 3 subunit mRNAS as well as polypeptide expression in primary cultured cerebral cortical neurons. Brain Res Mol Brain Res 24: 159-165.
112. Miller LG, Greenblatt DJ, Barnhill JG, Shader RI, (1988). Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function. J Pharmacol Exp Ther 246: 170-176.
113. Mitchell EA, Herd MB, Gunn BG, Lambert JJ, Belelli D, (2008). Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Neurochem Int 52: 588-595.
114. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, et al. (2000). Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142: 269-273.
115. Moran MH, Smith SS, (1998). Progesterone withdrawal I: pro-convulsant effects. Brain Res 807: 84-90.
116. Nemeroff CB, (2008). Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Neuron 59: 185-186.
117. Nordberg A, Wahlstrom G, (1992). Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines. J Neural Transm Gen Sect 88: 199-221.
118. Nyberg S, Wahlstrom G, Backstrom T, Sundstrom Poromaa I, (2004). Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder. Psychoneuroendocrinology 29: 767-777.
119. Nyberg S, Backstrom T, Zingmark E, Purdy RH, Poromaa IS, (2007). Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecol Endocrinol 23: 257-266.
120. O'Brien CP, (2005). Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66 (Suppl. 2): 28-33.
121. O'Brien C, (ed.) (2006). Drug addiction and drug abuse. In:, Brunton LL, Lazo JS, Parker KL, (eds). Goodman Gillman's The Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill: New York, pp. 607-627.
122. Odmark IS, Backstrom T, Jonsson B, Bixo M, (2004). Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being. Gynecol Endocrinol 18: 305-317. (Pubitemid 38922829)
123. Olsen RW, Tobin AJ, (1990). Molecular biology of GABAA receptors. FASEB J 4: 1469-1480.
124. Orchinik M, Weiland NG, McEwen BS, (1995). Chronic exposure to stress levels of corticosterone alters GABAA receptor subunit mRNA levels in rat hippocampus. Brain Res Mol Brain Res 34: 29-37.
125. Ottander U, Poromaa IS, Bjurulf E, Skytt A, Backstrom T, Olofsson JI, (2005). Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol Cell Endocrinol 239: 37-44.
126. Palmer AA, Moyer MR, Crabbe JC, Phillips TJ, (2002). Initial sensitivity, tolerance and cross-tolerance to allopregnanolone- and ethanol-induced hypothermia in selected mouse lines. Psychopharmacology (Berl) 162: 313-322.
127. Pandey SC, (1998). Neuronal signaling systems and ethanol dependence. Mol Neurobiol 17: 1-15.
128. Parizek A, Hill M, Kancheva R, Havlikova H, Kancheva L, Cindr J, et al. (2005). Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab 90: 395-403.
129. Patchev VK, Hassan AH, Holsboer DF, Almeida OF, (1996). The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15: 533-540.
130. Patchev VK, Montkowski A, Rouskova D, Koranyi L, Holsboer F, Almeida OF, (1997). Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest 99: 962-966.
131. Paul SM, Purdy RH, (1992). Neuroactive steroids. FASEB J 6: 2311-2322.
132. Pearlstein T, Howard M, Salisbury A, Zlotnick C, (2009). Postpartum depression. Am J Obstet Gynecol 200: 357-364.
133. Peng HY, Chen GD, Lee SD, Lai CY, Chiu CH, Cheng CL, et al. (2009). Neuroactive steroids inhibit spinal reflex potentiation by selectively enhancing specific spinal GABA(A) receptor subtypes. Pain 143: 12-20.
134. Penovich PE, Helmers S, (2008). Catamenial epilepsy. Int Rev Neurobiol 83: 79-90.
135. Pesold C, Caruncho HJ, Impagnatiello F, Berg MJ, Fritschy JM, Guidotti A, et al. (1997). Tolerance to diazepam and changes in GABA(A) receptor subunit expression in rat neocortical areas. Neuroscience 79: 477-487.
136. Protopopescu X, Tuescher O, Pan H, Epstein J, Root J, Chang L, et al. (2008). Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 108: 87-94.
137. Puia G, Santi MR, Vicini S, Pritchett DB, Purdy RH, Paul SM, et al. (1990). Neurosteroids act on recombinant human GABAA receptors. Neuron 4: 759-765.
138. Purdy RH, Morrow AL, Blinn JR, Paul SM, (1990). Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem 33: 1572-1581.
139. Purdy RH, Morrow AL, Moore PH Jr, Paul SM, (1991). Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 88: 4553-4557.
140. Reddy DS, (2003). Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol Sci 24: 103-106.
141. Reddy DS, (2004). Role of neurosteroids in catamenial epilepsy. Epilepsy Res 62: 99-118.
142. Reddy DS, (2006). Physiological role of adrenal deoxycorticosterone- derived neuroactive steroids in stress-sensitive conditions. Neuroscience 138: 911-920.
143. Reddy DS, Rogawski MA, (2000). Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther 295: 1241-1248.
144. van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, Mohler H, et al. (2004). Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24: 6785-6790.
145. Robinson GE, (2001). Psychotic and mood disorders associated with the perimenopausal period: epidemiology, aetiology and management. CNS Drugs 15: 175-184.
146. Roca DJ, Schiller GD, Friedman L, Rozenberg I, Gibbs TT, Farb DH, (1990). gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines. Mol Pharmacol 37: 710-719.
147. Rupprecht R, (2003). Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28: 139-168.
148. Sanna E, Motzo C, Usala M, Pau D, Cagetti E, Biggio G, (1998). Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes. J Neurochem 70: 2539-2544.
149. Sanna E, Mostallino MC, Busonero F, Talani G, Tranquilli S, Mameli M, et al. (2003). Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J Neurosci 23: 11711-11724.
150. Sassoe-Pognetto M, Follesa P, Panzanelli P, Perazzini AZ, Porcu P, Sogliano C, et al. (2007). Fluctuations in brain concentrations of neurosteroids are not associated to changes in gephyrin levels. Brain Res 1169: 1-8.
151. Saunders PA, Ito Y, Baker ML, Hume AS, Ho IK, (1990). Pentobarbital tolerance and withdrawal: correlation with effects on the GABAA receptor. Pharmacol Biochem Behav 37: 343-348. (Pubitemid 20339392)
152. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR, (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338: 209-216.
153. Segebladh B, Borgstrom A, Nyberg S, Bixo M, Sundstrom-Poromaa I, (2009). Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 201: 139 e1-139 e8.
154. Selye H, Stone H, (1944). Studies concerning the absorption and detoxification of anesthetic steroids. J Pharmacol Exp Ther 80: 386-390.
155. Serra M, Pisu MG, Littera M, Papi G, Sanna E, Tuveri F, et al. (2000). Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem 75: 732-740.
156. Serra M, Pisu MG, Mostallino MC, Sanna E, Biggio G, (2008). Changes in neuroactive steroid content during social isolation stress modulate GABAA receptor plasticity and function. Brain Res Rev 57: 520-530.
157. Siegel S, (1989). Psychoactive drugs: tolerance and sensitization. In:, Goudie AJ, Emmett-Oglesby MW, (eds). Pharmacological Conditioning and Drug Effects. Humana: Clifton, NJ, pp. 115-180.
158. Sieghart W, Sperk G, (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2: 795-816.
159. Slawecki CJ, Purdy RH, Ehlers CL, (2005). Electrophysiological effects of allopregnanolone in rats with a history of ethanol exposure. Alcohol Clin Exp Res 29: 66-74.
160. Smith SS, (2002). Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids 67: 519-528.
161. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X, (1998a). GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392: 926-930.
162. Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA, et al. (1998b). Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. J Neurosci 18: 5275-5284.
163. Stowe ZN, Nemeroff CB, (1995). Women at risk for postpartum-onset major depression. Am J Obstet Gynecol 173: 639-645.
164. Stromberg J, Backstrom T, Lundgren P, (2005). Rapid non-genomic effect of glucocorticoid metabolites and neurosteroids on the gamma-aminobutyric acid-A receptor. Eur J Neurosci 21: 2083-2088.
165. Sundstrom I, Nyberg S, Backstrom T, (1997). Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17: 370-381.
166. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Backstrom T, (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67: 126-138.
167. Sundstrom Poromaa I, Smith S, Gulinello M, (2003). GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 6: 23-41.
168. Tabakoff B, Kiianmaa K, (1982). Does tolerance develop to the activating, as well as the depressant, effects of ethanol? Pharmacol Biochem Behav 17: 1073-1076.
169. Tabakoff B, Melchior CL, Hoffman PL, (1982). Commentary on ethanol tolerance. Alcohol Clin Exp Res 6: 252-259.
170. Tasker J, (2004). Teaching resources. Regulation of GABA receptor activity by neurosteroids and phosphorylation. Sci STKE 2004: tr4.
171. Tehrani MH, Barnes EM Jr, (1991). Agonist-dependent internalization of gamma-aminobutyric acidA/benzodiazepine receptors in chick cortical neurons. J Neurochem 57: 1307-1312.
172. Tietz EI, Huang X, Chen S, Ferencak WF 3rd, (1999). Temporal and regional regulation of alpha1, beta2 and beta3, but not alpha2, alpha4, alpha5, alpha6, beta1 or gamma2 GABA(A) receptor subunit messenger RNAs following one-week oral flurazepam administration. Neuroscience 91: 327-341.
173. Tiffany ST, Drobes DJ, Cepeda-Benito A, (1992). Contribution of associative and nonassociative processes to the development of morphine tolerance. Psychopharmacology (Berl) 109: 185-190.
174. Timby E, Balgard M, Nyberg S, Spigset O, Andersson A, Porankiewicz-Asplund J, et al. (2006). Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 186: 414-424.
175. Tomson T, (1997). Epilepsy and Pregnancy. Wrightson Biomedical Publishing Ltd.: Petersfield.
176. Turkmen S, Lofgren M, Birzniece V, Backstrom T, Johansson IM, (2006). Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 139: 651-659.
177. Turkmen S, Wahlstrom G, Backstrom T, Johansson IM, (2008). Persistence of tolerance to the anaesthetic effect of allopregnanolone in male rats. Eur J Pharmacol 592: 73-80.
178. Tuveri A, Paoletti AM, Orru M, Melis GB, Marotto MF, Zedda P, et al. (2008). Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy. Epilepsia 49: 1221-1229.
179. Venard C, Boujedaini N, Belon P, Mensah-Nyagan AG, Patte-Mensah C, (2008). Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 153: 154-161.
180. Verkuyl JM, Hemby SE, Joels M, (2004). Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur J Neurosci 20: 1665-1673.
181. Wafford KA, (2005). GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr Opin Pharmacol 5: 47-52.
182. Wahlstrom G, (1979). Some aspects of the changes induced by chronic barbital treatments in the male rat. Drug Alcohol Depend 4: 221-233.
183. Wahlstrom G, (1998). A study of the duration of acute tolerance induced with hexobarbital in male rats. Pharmacol Biochem Behav 59: 945-948.
184. Wahlstrom G, Bolander HG, (1985). Dynamic aspects on acute tolerance to hexobarbital evaluated with an anesthesia threshold. Alcohol 2: 297-301.
185. Wallace MJ, Newton PM, Oyasu M, McMahon T, Chou WH, Connolly J, et al. (2007). Acute functional tolerance to ethanol mediated by protein kinase Cepsilon. Neuropsychopharmacology 32: 127-136.
186. Wang M, Seippel L, Purdy RH, Backstrom T, (1996). Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81: 1076-1082.
187. Wihlback AC, Nyberg S, Backstrom T, Bixo M, Sundstrom-Poromaa I, (2005). Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. Psychoneuroendocrinology 30: 38-50.
188. Wong PT, Yoong YL, Gwee MC, (1986). Acute tolerance to diazepam induced by benzodiazepines. Clin Exp Pharmacol Physiol 13: 1-8.
189. Wu Y, Rosenberg HC, Chiu TH, Zhao TJ, (1994). Subunit- and brain region-specific reduction of GABAA receptor subunit mRNAs during chronic treatment of rats with diazepam. J Mol Neurosci 5: 105-120.
190. Yehuda R, (2001). Biology of posttraumatic stress disorder. J Clin Psychiatry 62 (Suppl. 17): 41-46.
191. Yu S, Ho IK, (1990). Effects of acute barbiturate administration, tolerance and dependence on brain GABA system: comparison to alcohol and benzodiazepines. Alcohol 7: 261-272.
192. Yu R, Ticku MK, (1995). Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons. Mol Pharmacol 47: 603-610.
193. Yu R, Hay M, Ticku MK, (1996a). Chronic neurosteroid treatment attenuates single cell GABAA response and its potentiation by modulators in cortical neurons. Brain Res 706: 160-162.
194. Yu R, Follesa P, Ticku MK, (1996b). Down-regulation of the GABA receptor subunits mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment. Brain Res Mol Brain Res 41: 163-168.
195. Zhu WJ, Wang JF, Krueger KE, Vicini S, (1996). Delta subunit inhibits neurosteroid modulation of GABAA receptors. J Neurosci 16: 6648-6656.
196. Zhu D, Wang MD, Backstrom T, Wahlstrom G, (2001). Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat. Br J Anaesth 86: 403-412.
197. Zhu D, Birzniece V, Backstrom T, Wahlstrom G, (2004). Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. Br J Anaesth 93: 560-567.
198. Zonana J, Gorman JM, (2005). The neurobiology of postpartum depression. CNS Spectr 10: 792-799, 805.